Medical tech firm Nuwellis Q3 revenue down 6% yr/yr

Reuters11-12

Medical tech firm Nuwellis Q3 revenue down 6% yr/yr

Overview

Nuwellis Q3 revenue fell 6% yr/yr but rose 29% sequentially
Net income for Q3 was $468,000, with EPS of $0.56
Company initiated manufacturing transition to focus on U.S. market growth

Outlook

Nuwellis focuses on U.S. market growth, exiting international operations
Company enhances product offerings with new 24-hour circuit and catheter
Nuwellis advances pediatric product development with NIH-funded collaboration

Result Drivers

CONSUMABLE UTILIZATION - Sequential revenue growth driven by increased consumable utilization and stronger U.S. console sales
PEDIATRIC PRODUCT DEVELOPMENT - Accelerated through NIH-funded collaboration and new U.S. patent
U.S. MARKET FOCUS - Manufacturing transition to KDI Precision Manufacturing and exit of international operations

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q3 Sales		$2.22 mln
Q3 EPS		$0.56
Q3 Net Income		$468,000
Q3 Gross Profit		$1.45 mln
Q3 Income from Operations		-$2.70 mln
Q3 Pretax Profit		$468,000

Press Release: ID:nGNX7zQnQP

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2582837121?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 21:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582837121","market":"nz","top_or_hot":-1,"title":"Medical tech firm Nuwellis Q3 revenue down 6% yr/yr","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Medical tech firm Nuwellis Q3 revenue down 6% yr/yr</title></head><body><p><span>Overview</span></p><ul><li><p>Nuwellis Q3 revenue fell 6% yr/yr but rose 29% sequentially</p></li><li><p>Net income for Q3 was $468,000, with EPS of $0.56</p></li><li><p>Company initiated manufacturing transition to focus on U.S. market growth</p></li></ul><p><span>Outlook</span></p><ul><li><p>Nuwellis focuses on U.S. market growth, exiting international operations</p></li><li><p>Company enhances product offerings with new 24-hour circuit and catheter</p></li><li><p>Nuwellis advances pediatric product development with NIH-funded collaboration</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>CONSUMABLE UTILIZATION - Sequential revenue growth driven by increased consumable utilization and stronger U.S. console sales</p></li><li><p>PEDIATRIC PRODUCT DEVELOPMENT - Accelerated through NIH-funded collaboration and new U.S. patent</p></li><li><p>U.S. MARKET FOCUS - Manufacturing transition to KDI Precision Manufacturing and exit of international operations</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q3 Sales</p></td><td></td><td><p>$2.22 mln</p></td><td></td></tr><tr><td><p>Q3 EPS</p></td><td></td><td><p>$0.56</p></td><td></td></tr><tr><td><p>Q3 Net Income</p></td><td></td><td><p>$468,000</p></td><td></td></tr><tr><td><p>Q3 Gross Profit</p></td><td></td><td><p>$1.45 mln</p></td><td></td></tr><tr><td><p>Q3 Income from Operations</p></td><td></td><td><p>-$2.70 mln</p></td><td></td></tr><tr><td><p>Q3 Pretax Profit</p></td><td></td><td><p>$468,000</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nGNX7zQnQP</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medical tech firm Nuwellis Q3 revenue down 6% yr/yr</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedical tech firm Nuwellis Q3 revenue down 6% yr/yr\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-12 21:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Medical tech firm Nuwellis Q3 revenue down 6% yr/yr</title></head><body><p><span>Overview</span></p><ul><li><p>Nuwellis Q3 revenue fell 6% yr/yr but rose 29% sequentially</p></li><li><p>Net income for Q3 was $468,000, with EPS of $0.56</p></li><li><p>Company initiated manufacturing transition to focus on U.S. market growth</p></li></ul><p><span>Outlook</span></p><ul><li><p>Nuwellis focuses on U.S. market growth, exiting international operations</p></li><li><p>Company enhances product offerings with new 24-hour circuit and catheter</p></li><li><p>Nuwellis advances pediatric product development with NIH-funded collaboration</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>CONSUMABLE UTILIZATION - Sequential revenue growth driven by increased consumable utilization and stronger U.S. console sales</p></li><li><p>PEDIATRIC PRODUCT DEVELOPMENT - Accelerated through NIH-funded collaboration and new U.S. patent</p></li><li><p>U.S. MARKET FOCUS - Manufacturing transition to KDI Precision Manufacturing and exit of international operations</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q3 Sales</p></td><td></td><td><p>$2.22 mln</p></td><td></td></tr><tr><td><p>Q3 EPS</p></td><td></td><td><p>$0.56</p></td><td></td></tr><tr><td><p>Q3 Net Income</p></td><td></td><td><p>$468,000</p></td><td></td></tr><tr><td><p>Q3 Gross Profit</p></td><td></td><td><p>$1.45 mln</p></td><td></td></tr><tr><td><p>Q3 Income from Operations</p></td><td></td><td><p>-$2.70 mln</p></td><td></td></tr><tr><td><p>Q3 Pretax Profit</p></td><td></td><td><p>$468,000</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nGNX7zQnQP</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO0H1:1","article_id":"2582837121","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582837121","pubTimestamp":1762953817,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Medical tech firm Nuwellis Q3 revenue down 6% yr/yrOverviewNuwellis Q3 revenue fell 6% yr/yr but rose 29% sequentiallyNet income for Q3 was $468,000, with EPS of $0.56Company initiated manufacturing t","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","NUWE":"Nuwellis, Inc."},"translate_title":"医疗科技公司Nuwellis第三季度收入同比下降6%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NUWE":0.9},"content_text":"Medical tech firm Nuwellis Q3 revenue down 6% yr/yrOverviewNuwellis Q3 revenue fell 6% yr/yr but rose 29% sequentiallyNet income for Q3 was $468,000, with EPS of $0.56Company initiated manufacturing transition to focus on U.S. market growthOutlookNuwellis focuses on U.S. market growth, exiting international operationsCompany enhances product offerings with new 24-hour circuit and catheterNuwellis advances pediatric product development with NIH-funded collaborationResult DriversCONSUMABLE UTILIZATION - Sequential revenue growth driven by increased consumable utilization and stronger U.S. console salesPEDIATRIC PRODUCT DEVELOPMENT - Accelerated through NIH-funded collaboration and new U.S. patentU.S. MARKET FOCUS - Manufacturing transition to KDI Precision Manufacturing and exit of international operationsKey DetailsMetricBeat/MissActualConsensus EstimateQ3 Sales$2.22 mlnQ3 EPS$0.56Q3 Net Income$468,000Q3 Gross Profit$1.45 mlnQ3 Income from Operations-$2.70 mlnQ3 Pretax Profit$468,000Press Release: ID:nGNX7zQnQPFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2582837121","isCrawlerRequest":true}